Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Rischin, Danny; Migden, Michael R.; Lim, Annette M.; Schmults, Chrysalyne D.; Khushalani, Nikhil, I; Hughes, Brett G. M.; Schadendorf, Dirk; Dunn, Lara A.; Hernandez-Aya, Leonel; Chang, Anne Lynn S.; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C.; Geiger, Jessica L.; Gutzmer, Ralf; Alam, Murad; Okoye, Emmanuel; Mathias, Melissa; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Guminski, Alexander

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Author:

Rischin, Danny; Migden, Michael R.; Lim, Annette M.; Schmults, Chrysalyne D.; Khushalani, Nikhil, I; Hughes, Brett G. M.; Schadendorf, Dirk; Dunn, Lara A.; Hernandez-Aya, Leonel; Chang, Anne Lynn S.; Modi, Badri; Hauschild, Axel; Ulrich, Claas; Eigentler, Thomas; Stein, Brian; Pavlick, Anna C.; Geiger, Jessica L.; Gutzmer, Ralf; Alam, Murad; Okoye, Emmanuel; Mathias, Melissa; Jankovic, Vladimir; Stankevich, Elizabeth; Booth, Jocelyn; Li, Siyu; Lowy, Israel; Fury, Matthew G.; Guminski, Alexander

Tübinger Autor(en):

Eigentler, Thomas

Published in:

Journal For Immunotherapy of Cancer (2020), Bd. 8, Article e000775

Verlagsangabe:

Bmj Publishing Group

Language:

English

Full text:

http://dx.doi.org/10.1136/jitc-2020-000775

ISSN:

2051-1426